Acrivon Therapeutics (ACRV) Cash & Equivalents (2021 - 2026)
Acrivon Therapeutics (ACRV) posted Cash & Equivalents of $41.42 million for Q2 2026, down 1.1% from $41.9 million a year earlier but up 21.6% from the prior quarter.
Powered by 
Analysis
Acrivon Therapeutics (ACRV) Cash & Equivalents (2021 - 2026) Analysis & Trends
At the end of FY2025, Acrivon Therapeutics' Cash & Equivalents came in at $41.5 million, up 4.2% from FY2024.
- Annual Cash & Equivalents has increased for three consecutive years, though with a four-year compound annual growth rate of -19.7% (FY2021 to FY2025).
- In prior years, Acrivon Therapeutics' Cash & Equivalents was $39.82 million in FY2024 (+10.6%), $36.02 million in FY2023 (+22.0%), $29.52 million in FY2022 (-70.4%) and $99.6 million in FY2021.
- Quarterly Cash & Equivalents has run from a low of $3.61 million in Q3 2021 to a high of $99.6 million in Q4 2021 over five years.
- On a year-over-year basis, Cash & Equivalents increased in four of the last eight quarters, with growth averaging 9.7%.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was Q3 2022, with growth of 787.7%; the weakest was Q4 2022, with a decline of 70.4%.
- According to Business Quant data, Cash & Equivalents for the three prior quarters was $34.06 million (Q1 2026), $41.5 million (Q4 2025) and $35.41 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Acrivon Therapeutics | 85.27 Mn | 85.27 Mn | - | 41.42 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 41.42 Mn |
| Mar 31, 2026 | 34.06 Mn |
| Dec 31, 2025 | 41.50 Mn |
| Sep 30, 2025 | 35.41 Mn |
| Jun 30, 2025 | 41.90 Mn |
| Mar 31, 2025 | 39.15 Mn |
| Dec 31, 2024 | 39.82 Mn |
| Sep 30, 2024 | 43.42 Mn |
| Jun 30, 2024 | 46.01 Mn |
| Mar 31, 2024 | 24.61 Mn |
| Dec 31, 2023 | 36.02 Mn |
| Sep 30, 2023 | 29.86 Mn |
| Jun 30, 2023 | 38.07 Mn |
| Mar 31, 2023 | 27.49 Mn |
| Dec 31, 2022 | 29.52 Mn |
| Sep 30, 2022 | 32.08 Mn |
| Jun 30, 2022 | 83.86 Mn |
| Mar 31, 2022 | 90.77 Mn |
| Dec 31, 2021 | 99.60 Mn |
| Sep 30, 2021 | 3.61 Mn |
API Access
Acrivon Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ACRV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "ACRV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ACRV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();